GLAUKOS Corp
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
GKOS$236.19-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating Activities | ||
| Net loss | $(19,783) | $(18,146) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation | 2,909 | 2,651 |
| Amortization of intangible assets | 8,888 | 5,576 |
| Amortization of right-of-use lease assets | 1,085 | 1,078 |
| Deferred income tax benefit | - | (10) |
| Loss on disposal of fixed assets | 103 | 6 |
| Stock-based compensation | 19,144 | 12,986 |
| Unrealized foreign currency loss | 574 | 1,397 |
| Amortization of premium on short-term investments | (187) | (1,149) |
| Other liabilities | (2,249) | (1,091) |
| Allowance for doubtful accounts | 823 | 1,367 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (12,459) | (12,316) |
| Inventory | 832 | (1,668) |
| Prepaid expenses and other current assets | (2,985) | (2,339) |
| Accounts payable and accrued liabilities | (10,192) | (6,729) |
| Deposits and other assets | 971 | (134) |
| Net cash used in operating activities | (12,526) | (18,521) |
| Investing activities | ||
| Purchases of short-term investments | (31,353) | (74,743) |
| Proceeds from sales and maturities of short-term investments | 46,575 | 40,878 |
| Purchases of property and equipment | (3,959) | (1,938) |
| Investment in company-owned life insurance | (759) | (395) |
| Other investing activities | - | (750) |
| Net cash provided by (used in) investing activities | 10,504 | (36,948) |
| Financing activities | ||
| Proceeds from exercise of stock options | 19,330 | 4,082 |
| Proceeds from share purchases under Employee Stock Purchase Plan | 2,381 | 2,961 |
| Payment of employee taxes related to vested restricted stock units | (5,638) | (4,845) |
| Principal paid on finance lease | (304) | (248) |
| Net cash provided by financing activities | 15,769 | 1,950 |
| Effect of exchange rate changes on cash and cash equivalents | (311) | (1,855) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 13,436 | (55,374) |
| Cash, cash equivalents and restricted cash at beginning of period | 94,647 | 174,359 |
| Cash, cash equivalents and restricted cash at end of period | $108,083 | $118,985 |
| Supplemental disclosures of cash flow information | ||
| Taxes paid, net of refunds | $379 | $276 |
| Other interest paid | $1,042 | $1,058 |
| Supplemental schedule of noncash investing and financing activities | ||
| Purchases of property and equipment included in accounts payable and accrued liabilities | $863 | $502 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.